RecruitingNot ApplicableNCT06548061

D20054;LITT for Spine Tumors

Single Center Observational Study Using Spinal Laser Interstitial Thermal Therapy (sLITT) in the Treatment of Spine Metastases and Tumors


Sponsor

Dartmouth-Hitchcock Medical Center

Enrollment

25 participants

Start Date

May 16, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of this clinical study is to evaluate the efficacy and safety of spinal laser interstitial therapy in the treatment of metastatic spinal tumors. The investigators hypothesize that rates of local tumor control are comparable between conventional open surgical techniques and spinal laser interstitial therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called ClearPoint Prism for people with spinal metastases. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEClearPoint Prism

Spine laser interstitial therapy used instead of open decompression followed by spine stereotactic radiosurgery (SSRS).


Locations(1)

Dartmouth Health

Lebanon, New Hampshire, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06548061


Related Trials